Antiplatelet Therapy in the Prevention of Coronary Syndromes: Mode of Action, Benefits, Drawbacks

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|11|1|49-57

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.11, Iss.1, 2013-03, pp. : 49-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 192-202

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antiplatelet Therapy in Acute Coronary Syndromes: What is New in the Pipeline?

By  

Current Vascular Pharmacology, Vol. 10, Iss. 5, 2012-09 ,pp. : 606-618

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review

By  

Current Cardiology Reviews, Vol. 13, Iss. 4, 2017-10 ,pp. : 325-333

Bentham Science Publishers

Access to resources Recommend Favorite

Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention

By Saucedo Jorge  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 2, 2010-08 ,pp. : 200-209

Springer Publishing Company

Access to resources Recommend Favorite

Antiplatelet Therapy in Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 15, Iss. 2, 2003-04 ,pp. : 43-48

Karger

Access to resources Recommend Favorite